Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03895359 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Study acronym: TACE
StatusRecruiting
PhasePhase 3
Started2019-05-27
View on ClinicalTrials.gov ↗

Amendment history

2025-03-07
Study Status, Oversight, IPDSharing v5
Re-verified, no change to tracked fields
2023-10-25
Study Status, Sponsor/Collaborators v4
Collaborators+19 characters
CancerCare Manitoba
2021-11-10
Withdrawn→Recruiting Study Status, Study Design, Arms and Interventions, Outcome Measures, Contacts/Locations v3
Trial statusWithdrawn→Recruiting
Reason stoppedErroneously entered in ClinicalTrials.gov. Replacement submission has been approved.→not stated
Enrollment target0→128
Secondary endpoints12 entries, revised
Radiation Therapy Overall Toxicity Assessment Radiation Therapy Classic Radiation Toxicity Assessment Radiation Therapy Non-Classic Toxicity Assessment Overall Quality of Life (QOL) Liver Related Quality of Life (QOL)
Study sitesdetails revised at 1 of 1 site
2021-01-23
Recruiting→Withdrawn Study Status, Study Design, Contacts/Locations v2
Trial statusRecruiting→Withdrawn
Reason stoppednot stated→Erroneously entered in ClinicalTrials.gov. Replacement submission has been approved.
Enrollment targetestimated 128→confirmed 0
Study sitesdetails revised at 1 of 1 site
2019-07-23
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2019-06→confirmed 2019-05-27
Study sites0→1
2019-03-27
Original filing
Trans-arterial chemoembolization (TACE) is a standard treatment for patients with hepatocellular carcinoma (also called liver cancer). This is where chemotherapy is injected into the arteries of the liver and liver cancer. Unfortunately, the tumour grows after TACE in many patients. A new treatment using a specialized radiation procedure called Stereotactic ablative body radiotherapy (SBRT) may increase the chance to control liver cancer. SBRT allows radiation treatments to be focused more precisely, and be delivered more accurately than with older treatments. The purpose of this study is to find out if TACE alone versus TACE plus SBRT is better for you and your liver cancer.
Trial Details
NCT Number NCT03895359
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: CancerCare Manitoba
Conditions Hepatocellular Carcinoma
Enrollment 128 participants
Start Date 2019-05-27
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-11